Engineering Your Next Generation Tumour Models to Maximise Immuno-Oncology & Cellular Therapies Clinical Success

As we continue to see exciting preclinical and clinical updates in novel combination immno-oncology and cell-based therapies from drug developers, including the likes of Editas Medicine, Sanofi, BMS, Basilea, demand for advanced, well characterised and validated in vivo and 3D models surges.  

After 2 years of disruption, we are excited to bring the 11^th Tumour Models London back to serve drug developers, leading academics and model providers this December. This industry-led summit is the only forum dedicated to Preclinical and Translational scientists to engage and discuss strategies and technology advancements to overcome current model limitations, and more importantly, share novel model engineering and validation approaches to support clinical design.  

This much-anticipated in-person meeting will unite 120+ pioneers to help you 

Your 2022 Unmissable Case Studies:

• Cresendo Biologics shares their challenges and solutions for in vivo modelling the immunological activity of ni- and multi-specific therapeutics, and defining biomarker endpoints from mouse models to guide clinical decisions
• ImCheck Therapeutics reveals their experience in preclinical models for gamma delta T-cell therapy in cell-mediated antitumor immune response, and how to define the best combination strategies
• Ichnos Sciences Biotherapeutics SA discuss their in vivo strategy to improve T-Cell therapy clinical success, and how to define the translational relevance of different datasets
• Scenic Biotech assesses how to optimise TME targeting, which can lead to patient stratification to improve clinical utility
• Orion Corporation dissects how to recapitulate the human immune system for in humanised mice model

• GSK and AstraZeneca fireside chat to delve into organ-on-a-chip, whether we can recapitulate the TME and evaluate the potential of creating an autologous environment

This is your must-attend tumour model summit to reconnect with fellows from Pfizer, Sanofi, and GSK, and propel your clinical progression with confidence in 2023!